Market Growth Is Driven by Technological Innovations and An Increasing Incidence of Chronic Diseases.Pune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Global Positron Emission Tomography Market Size & Growth ...
Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical support services, is pleased to announce it has entered ...
Dr Vivek Verma, Associate Director-Surgical Oncology, Max Super Speciality Hospital Patparganj highlights that pediatric cancer, though a rare condition, remains one of the leading causes of death ...
GE HealthCare (GEHC) has delivered the first patient doses of Flyrcado or flurpiridaz F 18 njection, a first-of-its-kind unit dose positron ...
8d
News Medical on MSNBlood test for Alzheimer’s could replace costly and invasive spinal tapsResearchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...
News Medical on MSN7d
Neurofilament light as a translational biomarker from preclinical drug discovery to clinical applicationNeurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.
2d
GlobalData on MSNGE HealthCare delivers first PET MPI agent doses for CAD detectionGE HealthCare has delivered the initial subject doses of a positron emission tomography (PET) myocardial perfusion imaging ...
3d
Stockhead on MSNBargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 millionSeveral ASX-listed healthcare companies with low market caps are making strides in tackling cancer, a leading cause of death ...
Neurological disease diagnosis is one of the most significant challenges faced by modern clinics due to the complexity of the nervous system and the ...
2d
The Brighterside of News on MSNNew research raises alarm over Alzheimer's blood test reliabilityEarly detection of Alzheimer’s disease (AD) can improve treatment outcomes, but current testing methods still have ...
A discovery of how to target mutated proteins in tumors made a decade ago never matured into a surefire way of destroying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results